FAP has been proposed as one of the primary markers of CAFs being overexpressed in 90% of carcinomas, such as melanoma, colorectal, breast, ovarian, bladder, and lung (72, 73) and with high therapeutic potential (74). Here, FAP is linked to carcinoma.